NEO New Oncology, a Siemens Healthineers Company, is a part of a global organization with a strong network within the field of molecular diagnostics.
At NEO, we are committed to make a difference in cancer patients’ lives. We aim for improving cancer patient outcomes by being a strong partner for laboratories and hospitals to physicians, medical experts and pharmaceutical companies. Our solutions for molecular tumor profiling support guidance of targeted therapies and help to understand novel molecular biomarkers in clinical research. They thereby pave the way for innovations in precision medicine. Our tailor-made service takes the specific customer needs and challenges into account, enabling pathologies, researchers and industries to take advantage of our streamlined solutions for molecular cancer diagnostics and research.
By combining technology, competence and service, NEO provides a robust platform for molecular tumor profiling: NEOonsite. Learn more